1. . 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281—1357.
2. Rossiiskoe meditsinskoe obshchestvo po arterial'noi gipertonii (RMOAG), Vserossiiskoe nauchnoe obshchestvo kardiologov (VNOK). Diagnostika i lechenie arterial'noi gipertenzii. Rossiiskie rekomendatsii (chetvertyi peresmotr). Sist gipertenz 2010; 3: 5—26.
3. Shal'nova S.A. Epidemiologiya arterial'noi gipertenzii v Rossii: portret bol'nogo. Arter gipertenz 2008; 2: 56—62.
4. Kobalava Zh.D., Kotovskaya Yu.V., Starostina E.G. i dr. ot imeni issledovatelei ARGUS-2. Priverzhennost' patsientov k antigipertenzivnoi terapii i prepyatstviya k ee uluchsheniyu: Rezul'taty rossiiskoi nauchno-prakticheskoi programmy ARGUS-2. Ter arkh 2008; 3: 76—82.
5. Kobalava Zh.D., Villeval'de S.V., Isikova Kh.V. Effektivnost' strukturirovannykh obrazovatel'nykh programm i ratsional'nogo primeneniya ingibitora APF Prestariuma v otnoshenii povysheniya priverzhennosti i motivatsii k antigipertenzivnoi terapii. Rezul'taty issledovaniya PRIZMA. Klin farm i ter 2011; 4: 15—21.